Showing 4 posts of 4 posts found.


Opdivo shows biggest survival increase for head and neck cancer in 20 years in Phase III trials

April 19, 2016
Research and Development, Sales and Marketing Bristol-Myers Squibb, Cancer, blockbuster, head and neck cancer, nivolumab, oncology, opdivo, potential, squamous

Opdivo (nivolumab) showed the biggest increase in survival for patients with head and neck cancer for 20 years, according to …


Federal jury rules in MSD’s favour in Gilead blockbuster hepatitis C drug dispute

March 23, 2016
Medical Communications, Research and Development Gilead, MSD, blockbuster, federal court, federal jury, hit, patents, sales, sales hit, sofosbuvir, sovaldi

Gilead’s dominance of the hepatitis C market is under severe threat after a federal jury ruled in favour of MSD …


Future Focus: The industry’s top five biggest drug patent expirations in 2016

October 21, 2015
Manufacturing and Production, Research and Development biosimilars, blockbuster, generics, patent cliff, patents

From Humira to Cubicin, some multi-billion dollar drugs are set to be hit hard by patent expiries next year, and …

Latest content